Compartmentalized cyclic adenosine 3′,5′-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains

Molecular Biology of the Cell

Volumn 21, Issue 6, 2010, Pages 1097-1110

  Penmatsa, Himabindu ^a   Zhang, Weiqiang ^a   Yarlagadda, Sunitha ^a   Li, Chunying ^b   Conoley, Veronica G ^a   Yue, Junming ^a   Bahouth, Suleiman W ^a   Buddington, Randal K ^c   Zhang, Guangping ^d   Nelson, Deborah J ^d   Sonecha, Monal D ^e   Manganiello, Vincent ^f   Wine, Jeffrey J ^e   Naren, Anjaparavanda P ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MEMPHIS   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e STANFORD UNIVERSITY   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IIIA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME INHIBITION; EXPERIMENTAL PIG; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRACHEA MUCOSA; TRACHEA MUCUS;

ACTINS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE; CELL MEMBRANE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOSKELETON; FORSKOLIN; HUMANS; MEMBRANE MICRODOMAINS; PHOSPHODIESTERASE INHIBITORS; RESPIRATORY MUCOSA; SECOND MESSENGER SYSTEMS; SWINE; TETRAZOLES; THIAZOLIDINES;

SUIDAE;

EID: 77949472038     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-08-0655     Document Type: Article

References (65)

1. Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., and Welsh, M. J. (1991). Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253, 202-205.
2. Asirvatham, A. L., Galligan, S. G., Schillace, R. V., Davey, M. P., Vasta, V., Beavo, J. A., and Carr, D. W. (2004). A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines. J. Immunol. 173, 4806-4814.
3. Baillie, G. S., Scott, J. D., and Houslay, M. D. (2005). Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett. 579, 3264-3270.
4. Barnes, A. P., Livera, G., Huang, P., Sun, C., Oneal, W. K., Conti, M., Stutts, M. J., and Milgram, S. L. (2005). Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium. J. Biol. Chem. 280, 7997-8003.
5. Barnette, M. S. (1999). Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD). Prog. Drug. Res. 53, 193-229.
6. Bates, I. R., Hebert, B., Luo, Y., Liao, J., Bachir, A. I., Kolin, D. L., Wiseman, P. W., and Hanrahan, J. W. (2006). Membrane lateral diffusion and capture of CFTR within transient confinement zones. Biophys. J. 91, 1046-1058.
7. Bear, C. E., Li, C., Kartner, N., Bridges, R. J., Jensen, T. J., Ramjeesingh, M., and Riordan, J. R. (1992). Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68, 809-818.
8. Beavo, J. A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
9. Buxton, I. L., and Brunton, L. L. (1983). Compartments of cAMP and protein kinase in mammalian cardiomyocytes. J. Biol. Chem. 258, 10233-10239.
10. Cantiello, H. F. (1996). Role of the actin cytoskeleton in the regulation of the cystic fibrosis transmembrane conductance regulator. Exp. Physiol. 81, 505-514.
11. Chasan, B., Geisse, N. A., Pedatella, K., Wooster, D. G., Teintze, M., Carattino, M. D., Goldmann, W. H., and Cantiello, H. F. (2002). Evidence for direct interaction between actin and the cystic fibrosis transmembrane conductance regulator. Eur. Biophys. J. 30, 617-624.
12. Chen, Y., Lagerholm, B. C., Yang, B., and Jacobson, K. (2006). Methods to measure the lateral diffusion of membrane lipids and proteins. Methods 39, 147-153.
13. Choi, J. Y., Joo, N. S., Krouse, M. E., Wu, J. V., Robbins, R. C., Ianowski, J. P., Hanrahan, J. W., and Wine, J. J. (2007). Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. J. Clin. Invest. 117, 3118-3127.
14. Chung, K. F. (2006). Phosphodiesterase inhibitors in airway disease. Eur. J. Pharmacol. 533, 110-117.
15. Cobb, B. R., Fan, L., Kovacs, T. E., Sorscher, E. J., and Clancy, J. P. (2003). Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells. Am. J. Respir. Cell. Mol. Biol. 29, 410-418.
16. Compton, C. H., Gubb, J., Nieman, R., Edelson, J., Amit, O., Bakst, A., Ayres, J. G., Creemers, J. P., Schultze-Werninghaus, G., Brambilla, C., and Barnes, N. C. (2001). Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 358, 265-270.
17. Conti, M., and Beavo, J. (2007). Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481-511.
18. Cooper, D. M. (2005). Compartmentalization of adenylate cyclase and cAMP signalling. Biochem. Soc. Trans. 33, 1319-1322.
19. Dahan, M., Lévi, S., Luccardini, C., Rostaing, P., Riveau, B., and Triller, A. (2003). Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302, 442-445.
20. Degerman, E., Belfrage, P., and Manganiello, V. C. (1997). Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272, 6823-6826.
21. Galperin, E., and Sorkin, A. (2003). Visualization of Rab5 activity in living cells by FRET microscopy and influence of plasma-membrane-targeted Rab5 on clathrin-dependent endocytosis. J. Cell Sci. 116, 4799-4810.
22. Ganeshan, R., Nowotarski, K., Di, A., Nelson, D. J., and Kirk, K. L. (2007). CFTR surface expression and chloride currents are decreased by inhibitors of N-WASP and actin polymerization. Biochim. Biophys. Acta 1773, 192-200.
23. Giembycz, M. A., Corrigan, C. J., Seybold, J., Newton, R., and Barnes, P. J. (1996). Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol. 118, 1945-1958.
24. Giembycz, M. A. (2005). Phosphodiesterase-4, selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2, 326-333.
25. Halpin, D. M. (2008). ABCD of the phosphodiesterase family: interaction and differential activity in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 3, 543-561.
26. Huang, P., Lazarowski, E. R., Tarran, R., Milgram, S. L., Boucher, R. C., and Stutts, M. J. (2001). Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc. Natl. Acad. Sci. USA 98, 14120-14125.
27. Ianowski, J. P., Choi, J. Y., Wine, J. J., and Hanrahan, J. W. (2008). Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands. Pfluegers Arch. 457, 529-537.
28. Jin, S., Haggie, P. M., and Verkman, A. S. (2007). Single-particle tracking of membrane protein diffusion in a potential: simulation, detection, and application to confined diffusion of CFTR Cl- channels. Biophys. J. 93, 1079-1088.
29. Joo, N. S., Wu, J. V., Krouse, M. E., Saenz, Y., and Wine, J. J. (2001). Optical method for quantifying rates of mucus secretion from single submucosal glands. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L458-L468.
30. Kelley, T. J., Al-Nakkash, L., and Drumm, M. L. (1995). CFTR-mediated chloride permeability is regulated by type III phosphodiesterases in airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 13, 657-664.
31. Kelley, T. J., Thomas, K., Milgram, L. J., and Drumm, M. L. (1997). In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium. Proc. Natl. Acad. Sci. USA 94, 2604-2608.
32. Langeberg, L. K., and Scott, J. D. (2005). A-kinase-anchoring proteins. J. Cell Sci. 118, 3217-3220.
33. Lee, J. H., Richter, W., Namkung, W., Kim, K. H., Kim, E., Conti, M., and Lee, M. G. (2007). Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors. J. Biol. Chem. 282, 10414-10422.
34. Li, C., et al. (2005). Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J. Exp. Med. 202, 975-986.
35. Li, C., Krishnamurthy, P. C., Penmatsa, H., Marrs, K. L., Wang, X. Q., Zaccolo, M., Jalink, K., Li, M., Nelson, D. J., Schuetz, J. D., and Naren, A. P. (2007). Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 131, 940-951.
36. Li, C., and Naren, A. P. (2005). Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. Pharmacol. Ther. 108, 208-223.
37. Li, C., Roy, K., Dandridge, K., and Naren, A. P. (2004). Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane. J. Biol. Chem. 279, 24673-24684.
38. Liu, S., et al. (2005). Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther. 314, 846-854.
39. Liu, Y., Shakur, Y., Yoshitake, M., and Kambayashi Ji, J. (2001). Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc. Drug Rev. 19, 369-386.
40. McConnachie, G., Langeberg, L. K., and Scott, J. D. (2006). AKAP signaling complexes: getting to the heart of the matter. Trends Mol. Med. 12, 317-323.
41. Meacci, E., Taira, M., Moos, M., Jr., Smith, C. J., Movsesian, M. A., Degerman, E., Belfrage, P., and Manganiello, V. (1992). Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA 89, 3721-3725.
42. Naren, A. P., et al. (2003). A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc. Natl. Acad. Sci. USA 100, 342-346.
43. O'Grady, S. M., Jiang, X., Maniak, P. J., Birmachu, W., Scribner, L. R., Bulbulian, B., and Gullikson, G. W. (2002). Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells. J. Membr. Biol. 185, 137-144.
44. 2-adrenergic receptors by β-arrestins. Science 298, 834-836.
45. Pilewski, J. M., and Frizzell, R. A. (1999). Role of CFTR in airway disease. Physiol. Rev. 79, S215-S255.
46. Ponsioen, B., Zhao, J., Riedl, J., Zwartkruis, F., Van der Krogt, G., Zaccolo, M., Moolenaar, W. H., Bos, J. L., and Jalink, K. (2004). Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 5, 1176-1180.
47. Pozuelo Rubio, M., Campbell, D. G., Morrice, N. A., and Mackintosh, C. (2005). Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMAinduced phosphorylation of Ser428. Biochem. J. 392, 163-172.
48. Puxeddu, E., Uhart, M., Li, C. C., Ahmad, F., Pacheco-Rodriguez, G., Manganiello, V. C., Moss, J., and Vaughan, M. (2009). Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity. Proc. Natl. Acad. Sci. USA 106, 6158-6163.
49. Riordan, J. R. (2008). CFTR function and prospects for therapy. Annu. Rev. Biochem. 77, 701-726.
50. Riordan, J. R., et al. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
51. Rogers, C. S., et al. (2008). Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837-1841.
52. Schudt, C., Tenor, H., and Hatzelmann, A. (1995). PDE isoenzymes as targets for anti-asthma drugs. Eur. Respir. J. 8, 1179-1183.
53. Shakur, Y., Holst, L. S., Landstrom, T. R., Movsesian, M., Degerman, E., and Manganiello, V. (2001). Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog. Nucleic Acid Res. Mol. Biol. 66, 241-277.
54. Sheppard, D. N., and Welsh, M. J. (1999). Structure and function of the CFTR chloride channel. Physiol. Rev. 79, S23-S45.
55. Shin, D. D., Brandimarte, F., De Luca, L., Sabbah, H. N., Fonarow, G. C., Filippatos, G., Komajda, M., and Gheorghiade, M. (2007). Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am. J. Cardiol. 99, 4A-23A.
56. Smith, F. D., Langeberg, L. K., and Scott, J. D. (2006). The where's and when's of kinase anchoring. Trends. Biochem. Sci. 31, 316-323.
57. Taskén, K. A., Collas, P., Kemmner, W. A., Witczak, O., Conti, M., and Taskén, K. (2001). Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J. Biol. Chem. 276, 21999-22002.
58. Thompson, P. E., Manganiello, V., and Degerman, E. (2007). Re-discovering PDE3 inhibitors - new opportunities for a long neglected target. Curr. Top. Med. Chem. 7, 421-436.
59. Torphy, T. J. (1998). Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 157, 351-370.
60. Ullman, E. F., et al. (1996). Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. Clin. Chem. 42, 1518-1526.
61. Wine, J. J., and Joo, N. S. (2004). Submucosal glands and airway defense. Proc. Am. Thorac. Soc. 1, 47-53.
62. Wright, L. C., Seybold, J., Robichaud, A., Adcock, I. M., and Barnes, P. J. (1998). Phosphodiesterase expression in human epithelial cells. Am. J. Physiol. 275, L694-L700.
63. Yoo, D., Flagg, T. P., Olsen, O., Raghuram, V., Foskett, J. K., and Welling, P. A. (2004). Assembly and trafficking of a multiprotein ROMK (Kir 1.1) channel complex by PDZ interactions. J. Biol. Chem. 279, 6863-6873.
64. Zaccolo, M., and Pozzan, T. (2002). Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295, 1711-1715.
65. Zaccolo, M. (2006). Phosphodiesterases and compartmentalized cAMP signalling in the heart. Eur. J. Cell Biol. 85, 693-697.